New Research study of particle therapy over photons and electrons. For one, particles are stopped through a combination of radiation, collisional processes, and radiative effects. As a result, their energy transfer is greatest at the end of their track. This results in a dose profile with a plateau region, a sharp rise in dose at a well-defined energy-dependent depth, and a steep fall-off after the maximum. The tail of a particle is also formed through nuclear fragmentation processes.
There are two types of particle therapy. Active beam scanning and passive scattering. The first method enlarges the pencil-like mono-energetic beam with a range modulator. A second scatterer is sometimes needed to widen the beam further. The second type of particle therapy uses a collimator, made of brass or Rose’s metal. The first two types of treatment have their distinct advantages and disadvantages. The former is more effective for treating acute pain and is considered to be more effective than the latter.
Get Free Sample Report With Latest Covid19 Analysis @
https://www.coherentmarketinsights.com/insight/request-sample/3574
The growing prevalence of various types of cancers is driving the growth of the global particle therapy market. For instance, in 2018, according to the World Health Organization (WHO), cancer was the second leading cause of death and accounted for 9.6 million (about one in six deaths were due to cancer) deaths, globally. In addition, colorectal, prostate, stomach, lung, and liver cancer are common in men while breast, colorectal, lung, and thyroid cancer are common in women.
The growing adoption of inorganic growth strategies such as partnership by key players is another key factor propelling growth of the global particle therapy market. For example, in 2017, Royal Philips and Proton Partners International collaborated with Ion Beam Application (IBA). The main goal of the collaboration was to establish first compact proton therapy system in the Middle East. Hence, these factors are expected to drive the global particle therapy market growth over the forecast period.
High cost associated with particle therapy treatment of cancer is a key factor hampering growth of the market. For instance, in 2017, the cost of proton therapy is anywhere between US$ 30,000 to US$ 120,000. On the other hand, a course of treatment with radiosurgery is around US$ 8,000 to US$ 12,000. Thus, high cost of cancer treatment using particle therapy is projected to result in low demand for particle therapy over conventional radiation therapy.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/3574
North America is projected to hold dominant position in the global particle therapy market over the forecast period. The growing prevalence of various types of cancers such as prostate cancer is driving growth of the particle therapy market in this region. For instance, in 2018, in the U.S, according to the American Cancer Society (ACS), 164,690 new cases of prostate cancer and over 29,430 related deaths were reported. In addition, according to the same source, around 60% of the prostate cancer patients (men) of 65 years or older were diagnosed in 2018, in the U.S. Also, one in every nine men is expected to be diagnosed with prostate cancer.
Asia Pacific is projected to exhibit highest CAGR over the forecast period due to rising number of patients suffering from cancer. For instance, according to the WHO, around 70% of deaths are due to cancer in developing countries of Asia Pacific region.
Growing development of various cancer centers and proton therapy centers in the Asia Pacific region is expected propel Asia Pacific particle therapy market growth. For instance, in 2016, Shenzhen Hairong International Medical Development and Provision Asia entered into a joint venture to form Provision China and main objective of the company was to develop cancer center as well as proton center.
Some of the key players operating in the global particle therapy market include Ion Beam Applications, Provision Healthcare, Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., ProTom International, Inc., Advanced Oncotherapy Plc., Varian Medical Systems, Inc., Hitachi, Ltd., Danfysik A/S, Provision Healthcare, LLC, and IBA Worldwide.
Reasons to Buy this Particle Therapy Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Particle Therapy market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Particle Therapy market
➡Leading company profiles reveal details of key Particle Therapy market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Particle Therapy market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
Buy This Complete Business Report With Flat USD 2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/3574
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Particle Therapy Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Particle Therapy Industry Impact
Chapter 2 Global Particle Therapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global Particle Therapy (Volume and Value) by Type
2.3 Global Particle Therapy (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Particle Therapy Sales, Consumption, Export, Import by Regions
Chapter 5 North America Particle Therapy Market Analysis
Chapter 6 East Asia Particle Therapy Market Analysis
Chapter 7 Europe Particle Therapy Market Analysis
Chapter 8 South Asia Particle Therapy Market Analysis
Chapter 9 Southeast Asia Particle Therapy Market Analysis
Chapter 10 Middle East Particle Therapy Market Analysis
Chapter 11 Africa Particle Therapy Market Analysis
Chapter 12 Oceania Particle Therapy Market Analysis
Chapter 13 South America Particle Therapy Market Analysis
Chapter 14 Company Profiles and Key Figures in Particle Therapy Business
Chapter 15 Global Particle Therapy Market Forecast (2021-2028)
Chapter 16 Conclusions
Research Methodology….
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837